Back
ESC2025 Premium Access

Efficacy and safety of inclisiran in patients with and without type 2 diabetes mellitus: a subgroup analysis from the CHOLINET Registry

Session: Novel insights into lipid-lowering pharmacotherapy
Topic: Lipid-Lowering Agents
Speaker: Doctor F. Marzano (Naples, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Federica Marzano

University of Naples Federico II, Naples (Italy)
0 follower

7 more presentations in this session

The differences in lipid lowering therapies and the LDL-C goal attainment in patients with ASCVD documented by cardiologists and general practitioners in Germany.

Speaker: Professor O. Weingaertner (Jena, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Icosapent ethyl reduces cardiovascular risk across apolipoprotein b and fasting triglyceride rich lipoprotein levels

Speaker: Doctor W. Malick (New York City, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Inhibition of liver ApoC3 by GalNAc-conjugated siRNA RBD5044: first-in-human trial to evaluate the safety, pharmacokinetics (PK), and pharmacodynamic (PD) effects on atherogenic lipid profiles in heal

Speaker: Associate Professor A. Gabrielsen (Gothenburg, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of quadruple-drug fixed-dose single-pill combination therapy for hypertension and dyslipidemia: a prospective, multicenter, observational study

Speaker: Assistant Professor E. Park (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Long-term survival of heFH or ACS patients on PCSK9 targeted therapy based on the real-life data from poland

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Novel insights into lipid-lowering pharmacotherapy

Speakers: Doctor F. Marzano, Professor O. Weingaertner, Doctor W. Malick, Associate Professor A. Gabrielsen, Assistant Professor E. Park...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources